Hyperthermotherapy for postoperative local recurrences of rectal cancer.

M. Kuroda, A. Hizuta, H. Iwagaki, E. Makihata, J. Asaumi, K. Nishikawa, X. S. Gao, T. Nakagawa, I. Togami, Yoshihiro Takeda

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Between November 1984 and August 1992 we used hyperthermotherapy in six cases of local recurrence of rectal cancer. Hyperthermotherapy was performed on the average 8.7 times (range: 3-18) for each patient for 60 min each. All patients underwent combined radiotherapy and received a mean radiation dose of 42.5 Gy (range: 9-60 Gy). Five patients underwent heating within 1 h after irradiation and one patient simultaneously with the irradiation. Four patients underwent combined chemotherapy and two patients immunotherapy. Before the treatment all patients had painful lesions, but pain decreased posttherapeutically in five patients. Performance status improved in two patients. High carcinoembryonic antigen levels prior to the therapy in four patients decreased in all cases after treatment. Posttherapeutical computed tomograms revealed only minor response or no changes. After the treatment, four patients died of exacerbations of recurrent tumors and one patient of distant metastases. The patient who underwent simultaneous radiohyperthermotherapy is presently alive, in August 1992, 38 months after initiation of the treatment. The 50% survival time after initiation of the treatment was 25 months (range: 10-38 months). Hyperthermotherapy combined with radiotherapy, chemotherapy and/or immunotherapy was useful for the alleviation of pain in patients who developed local recurrence after surgery, and improved survival after recurrences can be expected.

Original languageEnglish
Pages (from-to)249-254
Number of pages6
JournalActa medica Okayama
Issue number4
Publication statusPublished - Aug 1993

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)


Dive into the research topics of 'Hyperthermotherapy for postoperative local recurrences of rectal cancer.'. Together they form a unique fingerprint.

Cite this